latrunculin b
Biologicalexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2007 (NCT00443924)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Actin, cytoplasmic 1INHIBITOR
ACTB inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ins115644
- latrunculin b
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03678597 | N/A | Sep 25, 2018 | Ibn Sina Hospital |
| NCT00443924 | Phase 1 | Mar 1, 2007 | Merck |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ibn Sina Hospital | Academic/Hospital | 1 | 1 | 1 | 2018 |
| Merck | For profit | 1 | 1 | 1 | 2007 |
2 organizations
Page 1 / 1